ReviewClinical journal of the American Society of Nephrology : CJASN2008
Recurrent glomerulonephritis after renal transplantation: an unsolved problem.
Review in Clinical journal of the American Society of Nephrology : CJASN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 77 citations in OpenAlex.
- Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis.Transplantation direct · 2024Article
- Association of Circulating 25-Hydroxyvitamin D and Recurrence of Glomerulonephritis in Kidney Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).Transplantation direct · 2024Article
- De novo collapsing glomerulopathy after kidney transplantation: Description of two cases.Clinical nephrology. Case studies · 2023Article
- Article
- Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021Article
- Therapeutic Options for Recurrence of Primary Focal Segmental Glomerulonephritis (FSGS) in the Renal Allograft: Single-Center Experience.Journal of clinical medicine · 2021Article
- Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem.International journal of molecular sciences · 2020Review
- Moving from transplant as a treatment to transplant as a cure.The Journal of clinical investigation · 2020Article
- Recurrent andFrontiers in immunology · 2019Review
- Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation.Frontiers in immunology · 2019Review
- Successful renal transplantation to a recipient with type II cryoglobulinemia: a case report.BMC nephrology · 2018Article
- Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.Scientific reports · 2018Article
- Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.International urology and nephrology · 2017Article
- Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.Transplantation · 2017Review
- De Novo Focal Segmental Glomerulosclerosis in Renal Allograft-Histological Presentation and Clinical Correlation: Single Centre Experience.Journal of clinical and diagnostic research : JCDR · 2017Article
- Increased glomerulonephritis recurrence after living related donation.BMC nephrology · 2017Article
- Complement related kidney diseases: Recurrence after transplantation.World journal of transplantation · 2016Review
- De novo glomerular diseases after renal transplantation.Clinical journal of the American Society of Nephrology : CJASN · 2014Review
- Incidence of post-transplant glomerulonephritis and its impact on graft outcome.Kidney research and clinical practice · 2012Article
- Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience.World journal of surgery · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesDespite advances in prevention of acute rejection and improved short- and long-term kidney graft survival, recurrent glomerulonephritis remains problematic and poorly characterized. This study analyzed prevalence and outcome of recurrent glomerulonephritis from various registries. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Definition, classification, and limitations in evaluating epidemiology of native and recurrent glomerulonephritis are discussed. Epidemiology of native glomerulonephritis as the cause of end-stage renal failure and subsequent recurrence of individual glomerulonephritis was evaluated using data from various registries, and pathogenesis of individual glomerulonephritis is discussed.
resultsAnalysis of data from transplant registries revealed that glomerulonephritis is an important cause of end-stage renal disease in white and pediatric recipients; however, glomerulonephritis as the cause of end-stage renal disease is not characterized well in black recipients, and many of them are perhaps labeled to have hypertensive nephrosclerosis as the cause of renal disease without renal biopsy. A systematic approach toward urinalysis after transplantation and utility of immunofluorescence and electron microscopic examination of renal biopsy tissues will identify the true prevalence of recurrent glomerulonephritis. Data on recurrent glomerulonephritis should be compiled by either using registry analysis or pooling data from multiple centers. This will provide true data on prevalence and outcome and could potentially initiate translational research studies.
conclusionsThe understanding of the pathogenesis of recurrent glomerulonephritis is critical to optimize prevention as well as to treat individual recurrent glomerulonephritis, which can enhance long-term graft survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.